Sequence for the leader RNA Synthesized by the New Jersey serotype of vesicular stomatitis virus is presented and its complementary sequence representing the 3'-terminal sequence of the genome RNA is deduced. Comparison with the leader RNA sequence of the serologically distinct Indiana strain reveals that the 3'-terminal region of the genomes of two viruses is highly conserved.
INTRODUCTION
Vesicular stomatitis virus (VSV), a prototype of negative strand viruses, contains a single-stranded genome RNA of molecular weight of 4 x 10 that serves as template for mRNA transcription ija vitro by an RNA polymerase associated with the purified virions (1, 2) . Five distinct mRNA species are synthesized ill vitro that code for the five structural proteins of VSV designated L, G, M, NS and N (3, 4) . Recent studies have shown that transcription initiates in vitro at the 3'-end of the genome RNA with synthesis of a 48 nucleotide long leader RNA followed by the sequential synthesis of the five mRNA species (5) . From the order of transcription, the gene order of the viral genome is established as 3' N-NS-M-G-L 5' (5) . A model for the biosynthesis of the mRNAs ±n vitro has been proposed that involves cleavage at specific sites on a growing precursor RNA molecule as the RNA polymerase transcribes the genome RNA (5) . Recently, the complete nucleotide sequence of the leader RNA synthesized by the Indiana serotype of VSV has been determined (6) .
From the complementary sequence of the leader RNA the 3'-terminal sequence of the genome RNA, which presumably serves as the binding and initiation site of the virion-associated RNA polymerase, was deduced. In this communication, we present the complete nucleotide sequence of the leader RNA synthesized by the New Jersey serotype of VSV which is serologically distinct from the Indiana strain. The results have enabled us to compare for the first time the 3'-terminal sequences of these two genomes in relation to their related-ness during evolution.
MATERIALS AND METHODS

Purification of VSV
The seed stock of the Ogden strain of New Jersey serotype of VSV was kindly provided by Dr. R. A. Lazzarrini, National Institutes of Health, Bethesda, Md. VSV was grown in baby hamster kidney cells (BHK-21, clone 13), adapted to suspension culture, and purified as described previously (7).
Synthesis and Purification of Leader RNA in Vitro
In vitro RNA polymerase reactions (1 ml) contained 50 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 5 mM MgCl 2 , 4 mM dithiothreitol, 0.05% triton N101, 0.1 mM UTP, 1 mM ATP, CTP, and GTP. Radioactive labeling of product RNA was as follows: for AMP labeling, 500 yCi/ml [a 32 P] ATP (11.21 Ci/mmole) was added to the reaction, and the amount of unlabeled ATP added was reduced to 0.4 mM. Reaction mixtures were incubated with 0.1 mg/ul of purified VSV for 6 hr at 30°. The reaction was terminated by the addition of SDS to 0.5% and the product RNA was directly extracted with phenol and purified by Sephadex G-50 chromatography, oligo(dT) cellulose chromatography, and electrophoresis on a 20% polyacrylamide slab gel as previously described (8, 9) . The leader RNA was recovered from the gel as described previously (10) .
Determination of the Nucleotide Sequence of Leader RNA Purified leader RNA which was separately labeled internally with each 32 of the [ P]-labeled ribonucleoside triphosphate, was digested with a 1:20 ratio of RNase T x to RNA in 2 ul of 10 mM Tris-HCl, 1 mM EDTA (pH 7.5) for 1 hr at 37°. The digest was spotted directly on a cellulose-acetate strip and subjected to high voltage electrophoresis and following direct transfer to a DEAE thin layer chromatography plate, the oligonucleotides were separated in a second dimension by homochromatography and identified by autoradiography (6) . The oligonucleotides were recovered from the DEAE plate and subjected to secondary digestions with RNase A followed by RNase T2 and analyzed as described previously (6) . RNase Phy 1 -4 0 ug/ml in 10 mM Na acetate (pH 4.5) for 7 min at 37°; RNase A, 0.5 ug/ml in 10 mM Tris-HCl, 1 mM EDTA (pH 7.5) for 10 min at 37°; RNase U 2 , 2.5 units/ml in 10 mM Na acetate (pH 4.5) for 12 min at 37°; RNase T]_, 50 units/ml in 10 mM Tris-HCl,. 1 mM EDTA (pH 7.5) for 3 min at 0°; RNase T 2 , 10 units/ml in 10 mM Na acetate (pH 4.5) for 5 min at 37°.
Reactions were terminated by adding 10 pi of 10 M urea in 50 mM Trisborate, 1 mM EDTA (pH 8.2) electrophoresis buffer and heating in a boiling water bath for 1 min. The digests were loaded directly onto a 20 x 40 cm 20% polyacrylamide slab gel and analyzed by electrophoresis as described previously (6) . Jersey serotype of VSV and purified by SDS phenol extraction followed by Sephadex G-50 chromatography as previously described (9) . Leader RNA was then separated from the poly(A) containing mRNAs by oligo(dT)-cellulose chromatography and from the remaining product RNA by electrophoresis on a 20% polyacrylamide gel. A distinct RNA band representing less than 5% of the total radioactivity applied to the gel migrated midway into the gel (Fig. 1 ) , and was recovered and used in subsequent studies.
Following recovery from gels, leader RNA labeled individually with each of the four [a P] ribonucleoside triphosphates, was digested with RNase Ti as described previously (6) and the resulting oligonucleotides resolved by two-dimensional fingerprinting using high voltage electrophoresis on cellulose acetate strips for the first dimensional separation and homochromotography on DEAE thin layer plates for separation in the second dimension. P] GMP-labeled leader RNA by polyacrylamide gel electrophoresis. Product RNA was synthesized jLn vitro in a 1 ml reaction mixture as detailed in Materials and Methods. The reaction mixture was incubated at 30° for 6 hr with 0.1 mg purified virions of clonally purified Ogden strain of New Jersey serotype of VSV. RNA synthesis was terminated by addition of SDS to 0.5% and the product RNA purified by phenol extraction and Sephadex G-50 chromatography (9) . Poly(A) containing mRNA was removed by oligo(dT)-cellulose chromatography and the leader RNA isolated from nonpoly (A) -containing product RNA by electrophoresis on a 20% polyacrylamide slab gel (140 V for 16 hr) as described previously (6, 9) . The band migrating in the center of the gel was located by autoradiography and recovered as previously described (6) . The position of the xylene cyanol dye included in the sample is indicated by XC.
32
RNase T^ digestion of [a P] GMP-labeled leader RNA yielded 6 oligonucleotides (numbered 1 to 6) as shown in Fig. 2 . To further characterize the 6 oligonucleotides, each was recovered from the DEAE plate and further digested with pancreatic RNase A to produce oligonucleotides terminating with a 3'-pyrimidine which were separated by high voltage electrophoresis on DEAE paper.
The resulting oligonucleotides were again eluted and treated with RNase T. and labeled bases were analyzed by paper electrophoresis. 32 P] GMP-labeled leader RNA was isolated as in Fig. 1 , digested with RNase Tj_, and characterized by high voltage paper electrophoresis on cellulose acetate strips for the first dimension and homochromatography on DEAE thin layer plates for the second dimension as detailed elsewhere (6) . The B surrounded by dots represents the position of the blue dye.
obtained from the leader RNA synthesized by the Indiana serotype (6) are included in Table I .
It can be seen that oligonucleotides numbers 1, 2, 3, and 6 are identical in sequence with the leader RNAs of both the serotypes. Oligonucleotide 4 has two bases transposed, and oligonucleotide 5 contains 28 bases in both cases but has differences in a few positions.
The secondary digestions of oligonucleotide number 5, shown in Table I, were consistent with the results of ladder sequencing described below.
Sequence Analysis on Polyacrylamide Gels
To determine the precise order of the T. oligonucleotides in the leader RNA, we utilized the recently reported sequencing gel techniques of Donis- Keller, Maxam and Gilbert (11) . New Jersey leader RNA was synthesized in the presence of [%] UTP and purified as described previously (9) . The 5'-terminal phosphates were removed with alkaline phosphatase and the terminus was labeled with [y^2P] ATP using polynucleotide kinase (11) . Following repurification on 20% polyacrylamide gels, the 5'[ 32 P]-labeled leader RNA was subjected to partial digestion with RNase A to locate pyrimidines, RNase Tt o locate G residues, RNase U2 to locate A residues, Phy I RNase to visualize C residues and RNase T2 to form a ladder from which to read the sequence. (Table II) 
Characterization of the 3'-Terminal Sequence
In order to characterize the last three unknown nucleotides in the leader, the following method was used. Leader RNA was labeled at the 3'-end with
[ pCp] using RNA ligase as described previously (6) . Such a reaction results in each leader RNA molecule being labeled with one pCp molecule at its 3'-end. Such studies using pCp labeled leader RNA were used successfully to determine the 3' terminal nucleotide sequences of the Indiana leader RNA (6). ] and RNA ligase (6) . Following repurification, the 3' [ 32 P]-labeled RNA was digested with a combination of RNase A and RNase T^, and the 3'-terminal oligonucleotide isolated by a DEAEcellulose column chromotography prior to digestion with RNase T2 (6). The resulting mononucleotides were separated by high voltage paper electrophoresis on Whatman 3 mM paper at 2600 volts for 75 min (6) . One cm strips were assayed for radioactivity in scintillation cocktail. The position of the four ribonucleoside monophosphate markers, located by UV light, are as indicated.
genome RNA of the New Jersey serotype of VSV is also presented. For comparison, the corresponding leader RNA and its complementary genome RNA sequence of the Indiana serotype of VSV (6) are also presented in Table II. There are some striking similarities in the sequences between the leader RNAs synthesized by two serologically distinct VSV; (a) both contain 48 nucleotides which are adenine-rich (50%) and terminate variably at the I n d i a n a 3 ' showing lack of sequence homologies between the mRNAs of these two serotypes of VSV (13, 14) should be re-investigated using less stringent conditions.
The sequence homology at the 3'-terminal region of the genomes of both viruses suggests that they possibly share common binding and initiation sequence at their 3'-terminal region for the virion-associated RNA polymerase.
In fact, the homology of the polymerase binding site may account for the fact that the New Jersey serotype of VSV interfere with the replication of VSV Indiana (15) . In addition, by in vivo complementation studies, it has been shown that the L protein of VSV New Jersey can complement the transcription defect of a VSV Indiana mutant that is temperature sensitive in the L protein gene (16) . By reconstituion experiment, it has been shown that both L and NS proteins of VSV are required for J-n vitro transcription using N-RNA protein complex as the template (17, 18) . Thus it seems that the L and NS proteins of both the viruses may recognize common sequence on the genome RNA for transcription or replication. It should then be possible using purified L and NS proteins of both viruses to retore transcription of the N-RNA complex of either virus. However, preliminary results using this approach were ambiguous (19) ; nevertheless, using more rigid experimental conditions, it may be possible to demonstrate this interaction.
It is interesting to note that the leader RNAs of both serotypes of VSV contain a polypurine sequence at their 3'-termini. These sequences have been implicated in the recognition site for the processing enzyme present in the virion (6) . Thus, it appears that both viruses may share not only a common strategy for biosynthesis of leader RNA and mRNAs, but also they may indeed share a common processing mechanism.
Finally, it appears from the extensive sequence hotnologies between the 3'-terminal portion of the genome RNA that these viruses may have evolved from a common ancestor. Since this portion of the genome RNA is involved in the binding and initiation by the RNA polymerase, the conservation of this sequence during evolution may be essential.
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